These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30596417)

  • 1. Synthesis of Triazolo- and Oxadiazolopiperazines by Gold(I)-Catalyzed Domino Cyclization: Application to the Design of a Mitogen Activated Protein (MAP) Kinase Inhibitor.
    Yamamoto K; Yoshikawa Y; Ohue M; Inuki S; Ohno H; Oishi S
    Org Lett; 2019 Jan; 21(2):373-377. PubMed ID: 30596417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile synthesis of fluorescent active triazapentalenes through gold-catalyzed triazole-alkyne cyclization.
    Cai R; Wang D; Chen Y; Yan W; Geise NR; Sharma S; Li H; Petersen JL; Li M; Shi X
    Chem Commun (Camb); 2014 Jul; 50(55):7303-5. PubMed ID: 24872118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Pd-catalyzed cyclization reaction of ureas for the synthesis of dihydroquinazolinone p38 kinase inhibitors.
    Schlapbach A; Heng R; Di Padova F
    Bioorg Med Chem Lett; 2004 Jan; 14(2):357-60. PubMed ID: 14698158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aza-analogue dibenzepinone scaffolds as p38 mitogen-activated protein kinase inhibitors: design, synthesis, and biological data of inhibitors with improved physicochemical properties.
    Karcher SC; Laufer SA
    J Med Chem; 2009 Mar; 52(6):1778-82. PubMed ID: 19253982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
    Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of enantioenriched aza-proline derivatives through gold(I)-catalyzed cyclization of chiral α-hydrazino esters.
    Bouvet S; Moreau X; Coeffard V; Greck C
    J Org Chem; 2013 Jan; 78(2):427-37. PubMed ID: 23167735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consecutive gold(I)-catalyzed cyclization reactions of o-(buta-1,3-diyn-1-yl-)-substituted N-aryl ureas: a one-pot synthesis of pyrimido[1,6-a]indol-1(2H)-ones and related systems.
    Sharp PP; Banwell MG; Renner J; Lohmann K; Willis AC
    Org Lett; 2013 Jun; 15(11):2616-9. PubMed ID: 23692341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition.
    Jerome KD; Rucker PV; Xing L; Shieh HS; Baldus JE; Selness SR; Letavic MA; Braganza JF; McClure KF
    Bioorg Med Chem Lett; 2010 Jan; 20(2):469-73. PubMed ID: 19969459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors.
    Pastor J; Oyarzabal J; Saluste G; Alvarez RM; Rivero V; Ramos F; Cendón E; Blanco-Aparicio C; Ajenjo N; Cebriá A; Albarrán MI; Cebrián D; Corrionero A; Fominaya J; Montoya G; Mazzorana M
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1591-7. PubMed ID: 22266039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aza-stilbenes as potent and selective c-RAF inhibitors.
    McDonald O; Lackey K; Davis-Ward R; Wood E; Samano V; Maloney P; Deanda F; Hunter R
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5378-83. PubMed ID: 16890436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 4-fluorophenyl-imidazole p38α MAPK, CK1δ and JAK2 kinase inhibitors.
    Seerden JP; Leusink-Ionescu G; Woudenberg-Vrenken T; Dros B; Molema G; Kamps JA; Kellogg RM
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3412-8. PubMed ID: 24930833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors.
    Huang S; Li R; Connolly PJ; Emanuel S; Middleton SA
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4818-21. PubMed ID: 16870444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors.
    Chun K; Park JS; Lee HC; Kim YH; Ye IH; Kim KJ; Ku IW; Noh MY; Cho GW; Kim H; Kim SH; Kim J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3983-7. PubMed ID: 23683591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formal alkyne aza-prins cyclization: gold(I)-catalyzed cycloisomerization of mixed N,O-acetals generated from homopropargylic amines to highly substituted piperidines.
    Kim C; Bae HJ; Lee JH; Jeong W; Kim H; Sampath V; Rhee YH
    J Am Chem Soc; 2009 Oct; 131(41):14660-1. PubMed ID: 19785427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity.
    Zhang L; Zhao J; Zhang B; Lu T; Chen Y
    Eur J Med Chem; 2018 Apr; 150():809-816. PubMed ID: 29602036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.
    Colletti SL; Frie JL; Dixon EC; Singh SB; Choi BK; Scapin G; Fitzgerald CE; Kumar S; Nichols EA; O'Keefe SJ; O'Neill EA; Porter G; Samuel K; Schmatz DM; Schwartz CD; Shoop WL; Thompson CM; Thompson JE; Wang R; Woods A; Zaller DM; Doherty JB
    J Med Chem; 2003 Jan; 46(3):349-52. PubMed ID: 12540232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient synthesis of vinyl substituted triazoles by Au(I) catalyzed alkyne activation.
    Duan H; Yan W; Sengupta S; Shi X
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3899-902. PubMed ID: 19361988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
    Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
    Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.